Pharmsynthez Cash Flow Statement

Financials in millions RUB. Fiscal year is January - December.

Millions RUB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2022	FY 2021	FY 2020
Period Ending	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-207.49	-697.55	-524.81
Depreciation & Amortization	27.51	31.96	44.4
Loss (Gain) From Sale of Assets	-	1.21	-6.01
Loss (Gain) From Sale of Investments	19.49	388.99	196.11
Loss (Gain) on Equity Investments	14.38	17.04	56.2
Provision & Write-off of Bad Debts	0.57	160.14	-
Other Operating Activities	46.81	-8.67	24.66
Change in Accounts Receivable	9.86	15.76	74.1
Change in Inventory	-8.96	9.63	7.69
Change in Accounts Payable	107.15	-36.82	-105.1
Change in Other Net Operating Assets	-12.66	-0.8	-
Operating Cash Flow	-3.35	-62.7	-232.76
Capital Expenditures	-3.47	-0.28	-9.68
Investing Cash Flow	-4.47	-1.9	-9.68
Long-Term Debt Issued	7.85	89.44	107.71
Total Debt Issued	7.85	89.44	107.71
Long-Term Debt Repaid	-33.56	-21.32	-16.09
Total Debt Repaid	-33.56	-21.32	-16.09
Net Debt Issued (Repaid)	-25.71	68.11	91.62
Issuance of Common Stock	23.74	-	87.26
Financing Cash Flow	-1.97	68.11	178.88
Foreign Exchange Rate Adjustments	3.68	1.37	7.05
Miscellaneous Cash Flow Adjustments	-0	0	0
Net Cash Flow	-6.12	4.88	-56.52
Free Cash Flow	-6.82	-62.97	-242.45
Free Cash Flow Margin	-1.80%	-14.37%	-65.23%
Free Cash Flow Per Share	-0.02	-0.21	-0.81
Cash Interest Paid	4.97	11.23	6.52
Cash Income Tax Paid	-	-	0.11
Levered Free Cash Flow	20.98	87.89	-339.32
Unlevered Free Cash Flow	46.81	110.63	-320.85
Change in Working Capital	95.39	-12.22	-23.31